GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

Similar documents
GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

BRCAplus. genetic testing for hereditary breast cancer

OvaNext. patient guide. genetic testing for hereditary breast, ovarian, and uterine cancer

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION

Genetic Risk Assessment for Cancer

A guide to genetic testing for hereditary cancers

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

Hereditary Cancer Risk Assessment for Gynecological Cancers. FarrNezhatMD.com

Carol Christianson, MS, CGC Genetic Counselor West Michigan Cancer Center

patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

Learn your genetic risk for the most common hereditary cancers.

Genetic testing for hereditary cancer

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

Genetic Risk Assessment for Cancer

Germline Testing for Hereditary Cancer with Multigene Panel

GEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T. Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

Are you at risk of Hereditary Cancer? Your Guide to the Answers

Why Test for Hereditary Cancer in Preventive Care?

The Next Generation of Hereditary Cancer Testing

Clinical Cancer Genetics

Hereditary Cancer Products

Multigene Panel Testing for Hereditary Cancer Risk

Germline Multigene Panel Testing in Oncology: Genetic Counseling Perspective

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention

Family Assessment. Objectives. Comprehensive Family History Important Inexpensive Underutilized genetic tool

Genetic testing and pancreatic disease

Genetics and Cancer Care. Cynthia Forster-Gibson, MD, PhD and Loren Mackay- Loder, MSc Genetics Program, THP

Genetic Testing: who, what, why?

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing

Myriad Financial Assistance Program (MFAP)

Management of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH

Hereditary Cancer Update Strengthening Linkages Workshop April 22, 2017

Genetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017

Understanding Your Positive Result. A guide to understanding your risk and taking action

Corporate Medical Policy

Genetic Testing for BRCA1 and BRCA2 Genes

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

Genetic Determinants, Risk Assessment and Management

The Role of Genetics in Ovarian Cancer Screening. Dawn DeLozier, Ph.D. Medical Geneticist, SAMC Associate Professor UCSF-Fresno

10/21/ New Release, Quest Diagnostics Nichols Institute, Valencia

DNA Genetic Cancer Risk Test. Test Report

Genetic Testing for BRCA1 and BRCA2 Genes

The Role of genetic Testing for Inherited Prostate Cancer Risk

Information for You and Your Family

11/29/2017. Genetics and Cancer ERICA L SILVER, MS, LCGC GENETIC COUNSELOR. Genetics 101. Transcription vs Translation

Proactive Patient Paves the Way for Genetic Testing of Eight Family Members

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

patient guide BrainTumorNext genetic testing for hereditary brain tumors Because knowing your risk can mean early detection and prevention

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing

Feasibility of Clinical Trial Implementation Genetically Eligible Prostate Cancer Patients Oliver Sartor, MD Cathryn E, Garvey, MS December 3, 2015

OBJECTIVES 8/25/2017. An attempt to organize the chaos

TumorNext-HRD with OvaNext: Paired Germline and Tumor Analyses of Genes Involved in

Robert Nathan Slotnick MD PhD FACOG FACMG (FF) Perinatologist and Director Medical Genetics

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Genetic Testing Today: What Genes Can Tell Us. Living Beyond Breast Cancer Conference Kara N. Maxwell, MD, PhD University of Pennsylvania

Germline Genetic Testing for Breast Cancer Risk

GeneHealth BreastGene_New qxp_Layout 1 21/02/ :42 Page 3 BreastGene GeneHealth UK

Assessing Your Patient s Breast Cancer Risk: Is Genetic Testing Necessary?

Genetic Testing for Lynch Syndrome

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR SUSCEPTIBILITY TO HEREDITARY CANCERS EFFECTIVE DATE: 06/19/14, 09/15/15.

patient guide RenalNext genetic testing for hereditary kidney cancer Because knowing your risk can mean early detection and prevention

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

Populations Interventions Comparators Outcomes Individuals: With a personal and/or family history suggesting an inherited cancer syndrome

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

The Value of Panel Testing in Inherited Breast Cancer Risk Assessment. Rodney J. Scott Division of Molecular Medicine

CASE STUDY. Germline Cancer Testing in A Proband: Extension of Benefits to Unaffected Family Members. Introduction. Patient Profile.

A pathogenic mutation was identified in the BRCA1 gene.

Objectives. Genetics in Cancer Treatment and Prevention. Genes

Prior Authorization. Additional Information:

Genetic counseling and testing. Shani Paluch-Shimon, MBBS, MSc Director, Breast Oncology Unit Shaare Zedek Medical Centre, Jerusalem Israel

Genetics & Precision Medicine Cancer Care

A COMPARISON OF CANCER HISTORIES AND MANAGEMENT OF WOMEN CARRIERS OF CHEK2 TRUNCATING AND MISSENSE MUTATIONS

Hereditary Aspects of Pancreatic Cancer

Disclosure. Gynecologic Cancer Genetics. Audience response. Audience response. What was the result? 47%

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Hereditary Breast and Ovarian Cancers: Risk Management Recommendations. Objectives

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

Genetic Panel Testing and Implications for Cancer Care

Hereditary Cancer Update: What do GPOs need to know?

Predictive and Diagnostic Testing for Cancer in Women. Aparna Rajadhyaksha MD

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR SUSCEPTIBILITY TO HEREDITARY CANCERS EFFECTIVE DATE: 06/19/14 REVISED DATE: 10/15/15, 10/20/16, 01/18/18

MEDICAL POLICY Genetic Testing for Breast and Ovarian Cancers

THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

Use of panel tests in place of single gene tests in the cancer genetics clinic

Genetic Testing For Ovarian Cancer: When, How And Who? Judith Balmaña, MD, PhD University Hospital Vall d Hebron Barcelona, Spain

CASE STUDY. Mutation-Specific Testing: Eligibility for PARP Inhibitor Therapy Established. Introduction. Patient Profile.

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

Transcription:

GYNplus genetic testing for hereditary ovarian and/or uterine cancer

What Are the Causes of Hereditary Ovarian and Uterine Cancer? uterine cancer ovarian cancer sporadic 70-80% hereditary 5% Lynch syndrome is the most common type of inherited uterine cancer sporadic 75-90% hereditary 10-25% BRCA1 and BRCA2 mutations cause 50-75% of inherited ovarian cancer

GYNplus: Genes and Associated Cancers BRIP1 BRCA1/BRCA2 MLH1, MSH2, MSH6, PMS2, EPCAM PALB2 PTEN RAD51C RAD51D TP53 Hereditary breast and ovarian cancer Lynch syndrome Cowden syndrome Li-Fraumeni syndrome Breast Ovarian Breast Ovarian Pancreatic Prostate Melanoma Colorectal Uterine Stomach Ovarian Small bowel Hepatobiliary tract Upper urinary tract Brain Pancreatic Sebaceous Prostate Breast Ovarian Pancreatic Male Breast Prostate (possible) Breast Thyroid Uterine Colorectal Kidney Melanoma Breast Ovarian Breast Ovarian Prostate Breast Cancer Sarcoma Brain Cancer Adrenocortical carcinoma Leukemia Gastrointestinal Genitourinary

Lifetime Ovarian and/or Uterine Cancer Risks with GYNplus Gene Mutations (%) 100 90 80 70 60 50 25-60 Ovarian cancer Uterine cancer 40 11-40 30 20 10 1.4 2.7 10-12 up to 9 5-9 increased up to 10 4-12 increased increased 0 General population BRCA1/ BRCA2 RAD51D BRIP1 RAD51C PALB2 PTEN Lynch syndrome TP53

What Do My Test Results Mean? genetic test results meaning implications Pathogenic Mutation Variant, Likely Pathogenic Variant, Unknown Significance (VUS) Variant, Likely Benign No Variants Detected Positive VUS Negative Medical management based on cancer risks specific to gene mutation Medical management based on personal and/or family history of cancer

Positive Test Results Result A mutation was found Cancer Risks Increased risk for certain types of cancer Cancer Screening and Prevention Recommendations based on genetic test result Genetic Testing For Family Members Recommend genetic counseling and consideration of genetic testing

Negative Test Results Result No mutations were found Cancer Risks Based on personal and/or family history Cancer Screening and Prevention Recommendations based on personal and/or family history Genetic Testing For Family Members May be considered in certain situations

Variant of Unknown Significance (VUS) Test Results Result A genetic change was found, but it is unclear if it causes increased risk for cancer Cancer Risks Based on personal and/or family history Cancer Screening and Prevention Recommendations based on personal and/or family history Genetic Testing For Family Members May be considered in certain situations

OvaNext genetic testing for hereditary ovarian, uterine and/or breast cancer

What Are the Causes of Hereditary Ovarian Cancer? brca1 & brca2 50-75% additional genes in gynplus & ovanext 20-40% sporadic 75-90% hereditary 10-25% unknown up to 30%

What Are the Cancer Risks by Gene Type? High risk genes Lifetime Cancer Risk Moderate risk genes Familial risk Population risk Risk Category

What Do the Cancer Gene Risk Levels Mean? High Risk Genes Have published recommendations for cancer screening and/or prevention Moderate Risk Genes May have newer recommendations for screening and/or prevention If no recommendations are available, screening may be based on family history and/or other risk factors Newly Described Genes Are associated with an increased lifetime risk of developing certain types of cancer, but the risk is not well-defined Recommendations may be based on family history and/or other risk factors

What are Signs of Hereditary Ovarian and Uterine Cancer? Multiple 2 or more primary cancers in the same person 3 or more ovarian, uterine, or other cancers on the same side of the family Young Uterine cancer diagnosed <50y Rare Ovarian cancer at any age

GYNplus OvaNext GYNplus and OvaNext: Genes and Associated Cancers genes ovarian uterine breast colorectal prostate stomach pancreatic others BRCA1, BRCA2 ü ü ü ü ü MLH1, MSH2, MSH6, PMS2, EPCAM ü ü ü ü ü ü ü PTEN ü ü ü ü TP53 ü ü ü ü ü ü ü ü PALB2 ü ü ü ü BRIP1, RAD51C ü ü ATM ü ü ü ü CDH1 ü ü ü CHEK2 ü ü ü DICER1 ü ü MUTYH ü ü NBN ü ü ü NF1 ü ü RAD51D ü ü ü BARD1, MRE11A, RAD50 SMARCA4 ü STK11 ü ü ü ü ü

Lifetime Cancer Risks with OvaNext Gene Mutations (%) up to 87 up to 60 up to 40 General Population Gene Mutation* 12 2-3 1-2 Breast Uterine Ovarian *Mutations in most OvaNext genes lead to an increased risk for some cancers in this graph, but not all. This graph represents the highest risks associated with some OvaNext genes.

What Do My Test Results Mean? genetic test results meaning implications Pathogenic Mutation Variant, Likely Pathogenic Variant, Unknown Significance (VUS) Variant, Likely Benign No Variants Detected Positive VUS Negative Medical management based on cancer risks specific to gene mutation Medical management based on personal and/or family history of cancer

Positive Test Results HIGH RISK GENE MODERATE RISK OR NEWLY DESCRIBED GENE Result A mutation was found A mutation was found Cancer Risks High risk (for certain types of cancer) Moderate risk: Moderately increased risk (for certain types of cancer) Newly described: Increased risk (for certain types of cancer), but exact risk is not yet defined Cancer Screening and Prevention Recommendations based on genetic test result Recommendations based on genetic test results and/or family history Genetic Testing For Family Members Recommend genetic counseling and consideration of genetic testing Recommend genetic counseling and consideration of genetic testing

Positive Test Results (high risk gene) Result A mutation was found Cancer Risks Increased risk for certain types of cancer Cancer Screening and Prevention Recommendations based on genetic test result Genetic Testing For Family Members Recommend genetic counseling and consideration of genetic testing

Negative Test Results Result No mutations were found Cancer Risks Based on personal and/or family history Cancer Screening and Prevention Recommendations based on personal and/or family history Genetic Testing For Family Members May be considered in certain situations

Variant of Unknown Significance (VUS) Test Results Result A genetic change was found, but it is unclear if it causes increased risk for cancer Cancer Risks Based on personal and/or family history Cancer Screening and Prevention Recommendations based on personal and/or family history Genetic Testing For Family Members May be considered in certain situations

50339.3265_v4 9.12.17